
    
      This observational case-control study will be conducted at the Department of Obstetrics and
      Gynecology, Cengiz Gokcek Public Hospital, Gaziantep, Turkey, between May 2020 and February
      2021. The protocol was approved by the Ethics Committee for Clinical Research of Gaziantep
      University (reference no: 2020/131). The study strictly will be adhered to the principles of
      the Declaration of Helsinki. All subjects will be included in the study gave oral and written
      informed consent. FGR was defined as an estimated fetal weight (grams) less than the 10th
      percentile for gestational age. Hadlock I formula were used to calculating estimated fetal
      weight percentiles. Every woman in the study population will be undergone obstetric
      ultrasound/doppler examination and fetal-maternal assessment will be carried out. Then, this
      study will be determined maternal plasma/urine/hair, cord plasma, placenta and breast milk
      tin (Sn), manganese (Mn), Vanadium (V), Magnesium (Mg), cobalt (Co), nickel (Ni), arsenic
      (As), chromium (Cr), cadmium (Cd), lead (Pb), mercury (Hg), antimony (Sb), aluminium (Al),
      zinc (Zn), copper (Cu), selenium (Se), iron (Fe), vitamin D, vitamin A, vitamin B12 and
      folate concentrations in women with FGR (n=55) compared to those of volunteer healthy
      pregnant women (n=55).
    
  